AIM IMMUNOTECH INC's ticker is AIM and the CUSIP is 00901B105. A total of 38 filers reported holding AIM IMMUNOTECH INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114,805 | -60.7% | 252,318 | -42.1% | 0.00% | – |
Q2 2023 | $291,824 | +11.2% | 435,558 | -28.7% | 0.00% | – |
Q1 2023 | $262,548 | -8.2% | 610,577 | -33.4% | 0.00% | – |
Q4 2022 | $285,903 | -64.9% | 916,649 | -34.5% | 0.00% | – |
Q3 2022 | $814,000 | -34.8% | 1,398,449 | -12.6% | 0.00% | – |
Q2 2022 | $1,248,000 | -40.9% | 1,599,304 | -19.7% | 0.00% | – |
Q1 2022 | $2,112,000 | +12.5% | 1,992,129 | -2.4% | 0.00% | – |
Q4 2021 | $1,878,000 | -61.0% | 2,041,382 | -14.4% | 0.00% | -100.0% |
Q3 2021 | $4,816,000 | -10.7% | 2,384,379 | -4.9% | 0.00% | 0.0% |
Q2 2021 | $5,391,000 | -5.2% | 2,507,390 | +0.1% | 0.00% | 0.0% |
Q1 2021 | $5,689,000 | +218.2% | 2,505,954 | +150.9% | 0.00% | – |
Q4 2020 | $1,788,000 | +3.2% | 998,815 | +24.0% | 0.00% | – |
Q3 2020 | $1,732,000 | +46.5% | 805,415 | +69.1% | 0.00% | – |
Q2 2020 | $1,182,000 | +2469.6% | 476,312 | +2524.2% | 0.00% | – |
Q1 2020 | $46,000 | – | 18,151 | +23782.9% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 76 | -99.9% | 0.00% | – |
Q3 2019 | $110,000 | – | 143,864 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
XTX MARKETS LLC | 11,019 | $20,000 | 0.04% |
Virtu Financial LLC | 103,807 | $186,000 | 0.02% |
ACT WEALTH MANAGEMENT, LLC | 10,000 | $18,000 | 0.01% |
SeaCrest Wealth Management, LLC | 48,873 | $87,000 | 0.01% |
Arkadios Wealth Advisors | 20,000 | $35,000 | 0.01% |
Traynor Capital Management, Inc. | 14,777 | $26,000 | 0.01% |
GSA CAPITAL PARTNERS LLP | 17,047 | $31,000 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 111,000 | $199,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 20,200 | $36,000 | 0.00% |
Tower Research Capital LLC (TRC) | 12,513 | $22,000 | 0.00% |